TransCode Therapeutics (RNAZ) P/E (2024 - 2026)
TransCode Therapeutics (RNAZ) P/E from Apr 1, 2024 to Jul 21, 2026. The TTM TransCode Therapeutics (RNAZ) P/E is -0.19. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of TransCode Therapeutics (RNAZ)
| Year | P/E | Change |
|---|---|---|
| 2026 | -0.19 | +9.62% |
| 2025 | -0.17 | -92.44% |
| 2024 | -2.25 | N/A |
Comparison TransCode Therapeutics (RNAZ) P/E with competitors
TransCode Therapeutics (RNAZ) P/E is -0.19.